The cleaved uPAR forms measured in blood have shown to be stronger prognostic biomarkers than the levels of the collective amount of uPAR in several types of cancers [10,13,32–34]; yet, the prognostic value of blood levels of the cleaved uPAR forms in patients with bladder cancer is unknown. This evidence concerns the gene PLAUR and urinary bladder carcinoma.